CADL

Latest SEC Filings & News for CADL

2 most recent filings and news items mentioning CADL. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/CADL/news?limit=20"

Pull CADL filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Chief Medical Officer resigns from Cadrenal Therapeutics

Cadrenal Therapeutics entered into a separation agreement with CMO James Ferguson III following his voluntary resignation for July 2026. This leadership change may impact the biotech firm's clinical development strategies.

View filing at SEC.gov →

Candel Therapeutics appoints Charles Schoch as Chief Financial Officer

Candel Therapeutics has entered into an employment agreement with Charles Schoch to serve as Chief Financial Officer effective June 12, 2026, with a base salary of $468,600 and target bonus of 40%. The appointment reflects the company's continued organizational development and fi

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.